CFH and endothelial dysfunction: Altogether, the previously discussed observations would suggest that in Asp/Asp homozygous diabetic patients, conformational modifications and/or lower plasma concentration of CFH impair its protective effect on endothelial cells against the attack of complement components flowing in the blood, leading to endothelial dysfunction (Heinen et al., 2007).